Christopher R. Fenimore - Aug 28, 2024 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Signature
/s/**Christopher R. Fenimore
Stock symbol
REGN
Transactions as of
Aug 28, 2024
Transactions value $
-$6,846,262
Form type
4
Date filed
8/29/2024, 04:27 PM
Previous filing
Feb 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Sale -$275K -228 -19.1% $1,204.79 966 Aug 28, 2024 2021 GRAT F1
transaction REGN Common Stock Sale -$923K -766 -79.3% $1,205.44 200 Aug 28, 2024 2021 GRAT F2
transaction REGN Common Stock Sale -$241K -200 -100% $1,206.30 0 Aug 28, 2024 2021 GRAT F3
transaction REGN Common Stock Sale -$2.69M -2.24K -61.88% $1,204.71 1.38K Aug 28, 2024 2022 GRAT F4
transaction REGN Common Stock Sale -$1.12M -928 -67.34% $1,205.49 450 Aug 28, 2024 2022 GRAT F5
transaction REGN Common Stock Sale -$543K -450 -100% $1,206.15 0 Aug 28, 2024 2022 GRAT F6
transaction REGN Common Stock Sale -$285K -236 -51.19% $1,205.67 225 Aug 28, 2024 by Trust for Daugh F7
transaction REGN Common Stock Sale -$241K -200 -88.89% $1,206.70 25 Aug 28, 2024 by Trust for Daugh F8
transaction REGN Common Stock Sale -$283K -235 -51.09% $1,205.67 225 Aug 28, 2024 by Trust for Son F9
transaction REGN Common Stock Sale -$241K -200 -88.89% $1,206.67 25 Aug 28, 2024 by Trust for Son F10
holding REGN Common Stock 15.3K Aug 28, 2024 Direct
holding REGN Common Stock 1.52K Aug 28, 2024 By 401(k) Plan
holding REGN Common Stock 1.9K Aug 28, 2024 By Trust F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents volume-weighted average price of sales of 228 shares of Company stock on August 28, 2024 at prices ranging from $1,204.76 to $1,204.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
F2 Represents volume-weighted average price of sales of 766 shares of Company stock on August 28, 2024 at prices ranging from $1,205.02 to $1,205.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
F3 Represents volume-weighted average price of sales of 200 shares of Company stock on August 28, 2024 at prices ranging from $1,206.09 to $1,206.63. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
F4 Represents volume-weighted average price of sales of 2,237 shares of Company stock on August 28, 2024 at prices ranging from $1,204.00 to $1,204.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
F5 Represents volume-weighted average price of sales of 928 shares of Company stock on August 28, 2024 at prices ranging from $1,205.00 to $1,205.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
F6 Represents volume-weighted average price of sales of 450 shares of Company stock on August 28, 2024 at prices ranging from $1,206.00 to $1,206.66. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
F7 Represents volume-weighted average price of sales of 236 shares of Company stock on August 28, 2024 at prices ranging from $1,205.51 to $1,205.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
F8 Represents volume-weighted average price of sales of 200 shares of Company stock on August 28, 2024 at prices ranging from $1,206.66 to $1,206.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
F9 Represents volume-weighted average price of sales of 235 shares of Company stock on August 28, 2024 at prices ranging from $1,205.51 to $1,205.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
F10 Represents volume-weighted average price of sales of 200 shares of Company stock on August 28, 2024 at prices ranging from $1,206.65 to $1,206.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
F11 These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person and the reporting person's spouse are trustees of the trust.